SUNPHARMA vs TMPV: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. SUN PHARMACEUTICAL IND L shows faster revenue growth, while TATA MOTORS PASS VEH shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SUNPHARMA leads 6; TMPV leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SUNPHARMA | TMPV |
|---|---|---|
| Sector | Healthcare | Automobile and Auto Components |
| Industry | Pharmaceuticals | Passenger Cars & Utility Vehicles |
Price
| Metric | SUNPHARMA | TMPV |
|---|---|---|
| Live Price | ₹1,760 | ₹279.9 |
| Day Change | 0.01% | 2.53% |
| Volume | 13.46 L | 64.77 L |
| 52-Week High | ₹2,046.9 | ₹688.6 |
| 52-Week Low | ₹1,583.7 | ₹272.2 |
| Distance from 52W High | -14.02% | -59.35% |
Valuation
| Metric | SUNPHARMA | TMPV |
|---|---|---|
| Market Cap | ₹4.22 L Cr | ₹1.03 L Cr |
| P/E Ratio | 34.85x | 1.3x |
| P/B Ratio | 5.04x | 0.92x |
| EPS | ₹12.06 | ₹2.1 |
| Book Value | ₹349.6 | ₹322.71 |
| Dividend Yield | 0.91% | 1.07% |
Growth
| Metric | SUNPHARMA | TMPV |
|---|---|---|
| Revenue Growth (TTM YoY) | 12.8% | -11.8% |
| EPS Growth (TTM YoY) | 25.6% | -32.9% |
| Qtr Sales Growth | 4.71% | -9.15% |
| Qtr Profit Growth | 7.07% | -85.39% |
Profitability & Leverage
| Metric | SUNPHARMA | TMPV |
|---|---|---|
| ROE | 11.76% | 21.37% |
| ROCE | 9.6% | 19.84% |
| Net Margin | 18.56% | 23.54% |
| Operating Margin | 22.81% | 11.39% |
| Debt to Equity | 0.6x | 0.09x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | SUNPHARMA | TMPV |
|---|---|---|
| Promoter Holding | 54.48% | 42.51%▼ 0.05 pp |
| FII Holding | 14.53%▼ 1.4 pp | 17.11%▼ 0.18 pp |
| DII Holding | 22.18%▲ 1.07 pp | 17.23%▲ 0.19 pp |
| Public Holding | 8.81%▲ 0.33 pp | 23.1%▲ 0.05 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUN PHARMACEUTICAL IND L and TATA MOTORS PASS VEH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.